4729-11-01 Definitions.

(A) "Controlled substance" has the same meaning as defined in division (C) of section 3719.01 of the Revised Code.

(B) "Schedules" mean controlled substance schedules I, II, III, IV, and V, respectively as defined in division (BB) of section 3719.01 of the Revised Code and subject to the findings for the placement on schedules as defined in Controlled Substances Act of 1970, 84 Stat. 1242, 21 U.S.C. 812 (July 9, 2012).

(C) "Synthetic" unless specifically excepted or unless listed in another schedule, means any substance, material, compound, mixture, or preparation that contains any quantity of a substance made artificially by chemical reaction.

(D) "Pharmacophore" means the portion of a chemical structure that confers the activity of the substance.

(E) "A report from an established forensic laboratory" means a laboratory report from the bureau of criminal identification and investigation, or a laboratory operated by another law enforcement agency, or a laboratory established by or under the authority of an institution of higher education that has its main campus in this state and that is accredited by the association of American universities or the north central association of colleges and secondary schools, primarily for the purpose of providing scientific services to law enforcement agencies and signed by the person performing the analysis as defined in division (A) of section 2925.51 of the Revised Code.

(F) "Synthetic cannabinoids" are drugs commonly found in herbal incense products (common names include but are not limited to: spice, blaze, devil's advocate, genie, smoke, sense, zohai, spike 99, and K2) that may mimic the effects of delta-9-tetrahydrocannabinol (THC), an active central nervous system constituent compound of marijuana.

(G) "Synthetic cathinones" are stimulants related to cathinone, the psychoactive substance found in the shrub catha edulis (khat). Synthetic cathinones (common names include, but are not limited to: research chemicals, plant food, and bath salts), which are beta-keto phenethylamine derivatives, produce pharmacological effects similar to methamphetamine.

Effective: 04/17/2014
R.C. 119.032 review dates: 04/17/2019
Promulgated Under: 119.03
Statutory Authority: 3719.44, 3719.28, 4729.26
Rule Amplifies: 3719.44, 3719.41